| ATCC | American Type Culture Collection |
| ATP | Adenosine triphosphate |
| BBB | Blood–brain barrier |
| BCI-2 | B-cell lymphoma 2 |
| CBSI | Colchicine-binding-site inhibitors |
| Log P | Lipophilicity |
| Log S | Solubility |
| MAPS | Microtubule-associated proteins |
| MaxTc | Max Tanimoto coefficients |
| MCF-10A | Human breast epithelial cell line |
| MDA-MB-321 | Human breast adenocarcinoma cell line |
| MMP | Mitochondrial Membrane Potential |
| NA | Not applicable |
| Pa | Probability of being active |
| PASS | Plan for Achieving Self Support |
| Pi | Probability of being inactive |
| PRa | Progesterone receptor alpha |
| RMSD | Root-mean-square deviation |
| SEA | Similarity ensemble approach |
| SP | Standard precision |
| VEGF | Vascular endothelial growth factor |
| XP | Extra precision |
| 3D | Three dimensional |
| ABC | ATP-binding cassette |
| ADME | Absorption, Distribution, Metabolism, and Excretion. |
| AKT-PI3 | protein kinase B/Phosphoinositide 3-kinase |
| CYP | Cytochrome P450 |
| DFF-45 | DNA fragmentation factor 45 |
| ER-LBD | Estrogen Receptor Ligand-Binding Domain |
| Era | Estrogen receptor alpha |
| HBSS | Hank’s Balanced Salt Solution |
| HCI | High content imagining |
| HCT8 | Human ileocecal adenocarcinoma cell line |
| HL60 | Human leukemia cell line |
| HTS | High-throughput screening |
| IC50 | Half-maximal inhibitory concentration |
| JAK-STAT | Janus Kinase/Signal Transducer and Activator of Transcription. |
| KAIMRC1 | King Abdullah international medical research center 1 cell line |
| KAIMRC2 | King Abdullah international medical research center 1 cell line |
| LD | Lethal dose |